‹ Home
Exported

AZ BioSense Community of Practice

The mission of the Arizona BioSense Workgroup is to work collaboratively as partners to build capacity and quality of BioSense syndromic surveillance in Arizona. Our vision is to improve population health and emergency response through the use of timely and effective syndromic surveillance. This space is a platform for our members to continue discussions and share cross-role topics and questions from providing the data to using syndromic data (clinician/IT/public health).
Laura ErhartJoli WeissTaylor Lutich, AZHayleigh McCall, Program Analyst III, Syndromic Surveillance at CSTEMatt RoachIrene, Senior Surveillance EpidemiologistAmanda Swanson, TB Special Projects Epidemiologist at AZDHSKaitlyn ChorbiAlyaa Altabbaa, Program Analyst at CSTEHeather VenkatLaura Fox, Environmental Public Health Tracking EpidemiologistChristina Mrukowicz, EpidemiologistSarah GieszlAmy LaiMichelle Kreutzberg-Martinez +189 others
Exploratory Analysis Subgroup/AZ BioSense Opioid Workgroup by Rachel Berg ·

✅ DOSE Syndromic Dashboard

The DOSE team just launched a new dashboard that features 8 syndrome definitions, ( 4 new syndromes: fentanyl, methamphetamine, cocaine, and benzodiazepine; and 4 revised: all drugs, all opioids, heroin, and all stimulants) for DOSE data from January 2018-March 2024. Historic data on the original four syndrome definitions were updated using revised syndrome definitions. Revised syndrome definitions fully incorporate the nesting of our syndrome definitions and more accurately process EHR data. This dashboard will be updated monthly throughout the OD2A-S NOFO period.
 
What is new in the DOSE syndromic dashboard:
  • 8 overdose syndromes (4 new, and 4 revised), with % change in rates by month and month/year
  • New data from July 2023 – March 2024
  • Expansion from 42 states and District of Columbia to 47 states and the District of Columbia
  • New diagram depicting nesting of our syndrome definitions: